CPT Raymond McKnight

CPT Raymond McKnight serves as the primary contracting officer for the W40M MRC0 West agency under the Department of the Army, responsible for securing mission-critical medical capabilities that ensure operational readiness across deployed environments. He manages the full lifecycle of procurements for advanced in-vitro diagnostic substances, surgical instrumentation, sterilization systems, and blood management technologies essential to high-acuity field care. His role is central to sustaining medical sovereignty by aligning acquisition strategies with the Army’s operational medical requirements, ensuring timely delivery of FDA-regulated and CE-marked medical devices that meet military-specific performance and ruggedization standards. CPT McKnight maintains enduring partnerships with leading medical technology providers including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These relationships are characterized by long-term contract performance, technical collaboration on compliance with MIL-STD specifications, and consistent reliance on vendors with proven track records in supplying sterile, single-use, and reusable surgical systems under austere conditions. His procurement approach prioritizes reliability, regulatory adherence, and supply chain resilience over cost alone, fostering trust-based vendor engagement with industry leaders in diagnostic and surgical innovation. CPT McKnight’s contracting portfolio reflects a strict preference for full and open competition, with 100% of awards issued under no set-aside classifications. This indicates a deliberate focus on accessing the broadest possible pool of qualified suppliers with the technical depth and regulatory certifications necessary to meet stringent military medical standards, rather than socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs. His approach underscores mission necessity as the overriding criterion for source selection. His primary procurement activity centers on NAICS 339112 — Surgical and Medical Instrument Manufacturing — encompassing diagnostic reagents, neuromonitoring equipment, autoclave-compatible instruments, and hemostatic and transfusion systems. He possesses deep technical expertise in the regulatory and performance requirements governing medical devices used in combat support hospitals and forward surgical teams, ensuring acquisitions align with DoD medical logistics and readiness frameworks.